News | Proton Therapy | July 18, 2017

IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute

Contract signed with Virginia facility for two-room Proteus Plus proton therapy system

IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute

July 18, 2017 — IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy solution, each treatment room equipped with pencil beam scanning capability and integrated cone beam computed tomography (CBCT). Inova plans to start treating patients by 2020 at the Inova Schar Cancer Institute on the Inova Center for Personalized Health campus in Annandale, Va.

“The addition of proton therapy to our oncology services will bring our patients access to one of the most significant technology innovations in the treatment of cancer,” said Thomas Graves, vice president for cancer services and associate director for administration at the Inova Schar Cancer Institute. “The Institute will be housed at the Inova Center for Personalized Health, offering patients easy access from anywhere in Virginia and the Metro DC area. This advanced technology will be an excellent complement to the best in class oncology services we offer today.”

Gopal Bajaj, M.D., chairman and medical director of radiation oncology at the Inova Schar Cancer Institute, added: “Being able to provide such a powerful cancer treatment truly puts Inova’s radiation oncology department at the forefront of cancer treatment delivery. Proton therapy is an exciting alternative to traditional radiation treatment protocols, allowing us to treat many cancer patients more effectively, and often without the uncomfortable side effects that traditional treatments may cause. This technology will have a very positive impact on the thousands of people in our community who are touched by cancer.”

For more information: www.iba-worldwide.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...